CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 5,774 enrolled
Drug / intervention
Propofol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01975064
NCT01975064Phase 4Completed

A Randomized, Open-label Study to Compare Propofol Anesthesia With Sevoflurane Anesthesia in Terms of Overall Survival in Patients With Surgical Intervention for Either Breast-, Colon- or Rectal Cancer

Uppsala University·interventional·Posted Nov 4, 2013·Updated Dec 14, 2022

In Brief

A Phase 4 clinical trial evaluating Propofol and Sevoflurane for Breast Neoplasms and 2 related conditions. Completed, enrolled 5,774 participants across 15 sites in 3 countries.

Detailed Summary

The purpose of this study is to determine whether anesthesia maintained with propofol results in better one- and five-year-survival than anesthesia maintained with sevoflurane.

Study Details

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 4, 2013
Enrollment StartNov 1, 2013
Primary CompletionAug 31, 2022
TodayJul 2, 2026
Enrollment to primary: 8.8 yearsPosted 12.7 years ago

Interventions

Propofoldrug

Propofol will be infused individually for a sufficient level of anesthesia during the entire surgical procedure.

Sevofluranedrug

Sevoflurane will be administered by vaporizer individually for a sufficient level of anesthesia during the entire surgical procedure.